FF
RMD icon

FourThought Financial’s ResMed RMD Stock Holding History

FourThought Financial’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$15K Buy
69
+49
+245% +$11.2K ﹤0.01% 936
2022
Q2 		$4K Hold
20
– – ﹤0.01% 1214
2022
Q1 		$5K Buy
20
+3
+18% +$726 ﹤0.01% 1199
2021
Q4 		$4K Sell
17
-57
-77% -$14.8K ﹤0.01% 1272
2021
Q3 		$19K Hold
74
– – ﹤0.01% 964
2021
Q2 		$18K Hold
74
– – ﹤0.01% 972
2021
Q1 		$14K Hold
74
– – ﹤0.01% 987
2020
Q4 		$15K Buy
+74
New +$14.8K ﹤0.01% 940

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

FourThought Financial's RMD Position: Q3 2022 in Review

FourThought Financial increased its ResMed (RMD) stake by 245% in Q3 2022, buying an estimated $11.2K and bringing the position to 69 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #936.

FourThought Financial first reported a position in RMD in Q4 2020 and has held it in 8 quarters since. The position peaked at $19K in Q3 2021. 668 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • FourThought Financial held 69 shares of ResMed worth $15K as of Q3 2022.
  • FourThought Financial bought 49 ResMed shares in Q3 2022, an estimated $11.2K.
  • ResMed made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #936 holding.
  • FourThought Financial first reported a position in ResMed in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's ResMed position peaked at $19K in Q3 2021.
  • 668 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.